Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Moleculin Biotech (MBRX)
Technical Analysis Report for NASDAQ stock MBRX Moleculin Biotech. Dated: 13 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MBRX Moleculin Biotech then click here. or read Experts views on Moleculin Biotech or Forecast & share price targets of Moleculin Biotech
Moleculin Biotech Opened at 2.25 and Closed at: 2.21, which is -3.62% of previous session's close. It moved within a range of 2.18 and 2.29
The session was a Bearish session with an average volume of 117800, which is 5.26% of previous session's volumes.
A Dead cross was found 3 days back on short term averages
Support for tomorrow is 2.14 and resistance for tomorrow is 2.25
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.16, 2.12 resistance for tomorrow's hourly charts is 2.27, 2.34
10 Day SMA for Moleculin Biotech (MBRX) is 2.56 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Moleculin Biotech (MBRX) is 2.72 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Moleculin Biotech (MBRX) is 2.56 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.48 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Moleculin Biotech is 2.58 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Moleculin Biotech is at 2.72 and 200 DMA is at 2.58, while 50 DMA and 100 DMA are at 2.56 and 2.48 respectively
Moleculin Biotech (MBRX) moving average of 20 SMA is at 2.72 and 20 EMA is at 2.58
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Jul | 2.21 | 2.72 | 2.58 |
| 10 Fri Jul | 2.29 | 2.75 | 2.62 |
| 09 Thu Jul | 2.45 | 2.76 | 2.66 |
| 08 Wed Jul | 2.35 | 2.76 | 2.68 |
| 07 Tue Jul | 2.28 | 2.77 | 2.71 |
| 06 Mon Jul | 2.40 | 2.77 | 2.76 |
Moleculin Biotech (MBRX) moving average of 50 SMA is at 2.56 and 50 EMA is at 2.61
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Jul | 2.21 | 2.56 | 2.61 |
| 10 Fri Jul | 2.29 | 2.57 | 2.63 |
| 09 Thu Jul | 2.45 | 2.57 | 2.64 |
| 08 Wed Jul | 2.35 | 2.57 | 2.65 |
| 07 Tue Jul | 2.28 | 2.58 | 2.66 |
| 06 Mon Jul | 2.40 | 2.58 | 2.68 |
Moleculin Biotech (MBRX) moving average of 100 SMA is at 2.48 and 100 EMA is at 2.64
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Jul | 2.21 | 2.48 | 2.64 |
| 10 Fri Jul | 2.29 | 2.5 | 2.65 |
| 09 Thu Jul | 2.45 | 2.53 | 2.66 |
| 08 Wed Jul | 2.35 | 2.54 | 2.66 |
| 07 Tue Jul | 2.28 | 2.56 | 2.67 |
| 06 Mon Jul | 2.40 | 2.58 | 2.68 |
Moleculin Biotech (MBRX) moving average of 200 SMA is at 2.58 and 200 EMA is at 2.46
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Jul | 2.21 | 2.58 | 2.46 |
| 10 Fri Jul | 2.29 | 2.58 | 2.46 |
| 09 Thu Jul | 2.45 | 2.57 | 2.46 |
| 08 Wed Jul | 2.35 | 2.56 | 2.46 |
| 07 Tue Jul | 2.28 | 2.55 | 2.46 |
| 06 Mon Jul | 2.40 | 2.54 | 2.46 |
Moleculin Biotech has performed better than Synergetics Usa in short term. Holding Moleculin Biotech could be a better choice for now!
Supernus Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 22.91% more returns!
Sensus Healthcare has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Sensus Healthcare, about 29.94% more returns!
Rocket Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Rocket Pharmaceuticals, about 51.56% more returns!
Macrogenics Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Macrogenics Inc, about 29.93% more returns!
Acadia Healthcare has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Acadia Healthcare, about 40.52% more returns!
Align Technology has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Align Technology, about 19.58% more returns!
Moleculin Biotech has performed better than Accuray Incorporated in short term. Holding Moleculin Biotech could be a better choice for now!
Axogen Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Axogen Inc, about 8.13% more returns!
Biomarin Pharmaceutical has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 22.1% more returns!
Curis Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Curis Inc, about 1047.24% more returns!
Delcath Systems has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Delcath Systems, about 26.1% more returns!
Editas Medicine has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Editas Medicine, about 42.69% more returns!
Fennec Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 35.73% more returns!
Genprex Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Genprex Inc, about 0.66% more returns!
Icon Plc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Icon Plc, about 29.92% more returns!
Inc Research has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Inc Research, about 25.49% more returns!
Inmune Bio has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Inmune Bio, about 66.29% more returns!
Iovance Biotherapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 15.31% more returns!
Moleculin Biotech Technical analysis of indicators
Price action analysis of Moleculin Biotech (MBRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Moleculin Biotech stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Moleculin Biotech in short term and the sell signal is strong.
Moleculin Biotech Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Moleculin Biotech in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Moleculin Biotech is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.87 and Moleculin Biotech MBRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Moleculin Biotech MBRX stock. Volume based technical analysis of Moleculin Biotech MBRX stock is negative.
Moleculin Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MBRX Moleculin Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MBRX Experts View which covers a lot of information including buying and selling signals
MBRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Moleculin Biotech or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


